Table 2.
Groups | Vaccines Injected | Dose | Challenge Virus | Route of Injection | |
---|---|---|---|---|---|
G1 | 5 pigs/each | Ingelvac PRRS MLV | 2 mL/piglet | (QH-08 at (2 × 106 TCID50) 2 mL/piglet | Intramuscularly |
G2 | CH-1α | 2 mL/piglet | |||
G3 | JXA1 | 2 mL/piglet | |||
G4 | JXA1-R MLV | 2 mL/piglet | |||
infected control | 3 pigs/each | No vaccine | PBS-2 mL/piglet | ||
non-infected control | PBS-2 mL/piglet |